Global leader in ophthalmological diagnostic equipment, refractive optometry equipment and wider equipment for opticians.
Luneau Technology is a recognised innovator in ophthalmic technology. Founded in 1994 by Marc Abitbol, the Group grew rapidly with the launch of cutting-edge products and following successful acquisitions, including some companies which were larger than itself. In 2014, Luneau Technology was looking for a partner to continue its international growth. We built a strong relationship with Marc who was particularly impressed by our partnership approach and our international credentials. During our four-year partnership, we completed three acquisitions in France, the US and China to cement its position as the global leader.
MML successfully exited its investment in Luneau Technology in 2019 to Caravelle, a family office.
Fund | Partnership Capital |
Region | Europe |
Deal Status | Realised |
Sector | Healthcare |
After completing a PhD in Optics, I started Visionix in 1994 which launched the first wavefront product for ophthalmic diagnosis. In 2003, Visionix acquired Luneau Technology and more than doubled its size. Today we are proud to say that over 80,000 ophthalmic professionals use Luneau Technology devices worldwide.
Luneau Technology is all about innovation, developing break-through solutions for eye diagnosis. We recently launched the VX650 device which is the first and only multi-modal solution for early detection and follow-up of major anterior and posterior ocular pathologies in a single device. Our "new frontier" is the telehealth challenge: addressing the issue of doctor shortage in remote areas and providing access to eye diagnosis for everyone.
I thought Henry-Louis and his team were the right cultural fit for Luneau Technology and they gave me confidence they could help us deliver our strategic objectives. Luneau Technology generates more than 85% of its revenues outside of France and is distributed in 150 countries so it made sense to choose a partner who were culturally aligned and had the international credentials to support our growth.
It was an exciting journey with important milestones including acquisitions in the US, Asia and Europe. We had a rich and informal working relationship. The MML team are commercial, strategic and always available to brainstorm when required. They were strong strategic partners throughout the journey.
For investors in MML Fund VI, MML Ireland I & MML Ireland II
For investors in MML Fund VII
